Literature DB >> 6307587

Naloxone in septic shock.

J S Groeger, G C Carlon, W S Howland.   

Abstract

Naloxone, 0.3 mg/kg of a 10 mg/ml solution, was administered as a single bolus to patients in septic shock if their systolic blood pressure (BP) was less than 100 mm Hg or MAP less than 70 mm Hg with evidence of renal or cerebral hypoperfusion. Patients with chronic or acute (less than 12 h) administration of narcotics were excluded. Ten patients received naloxone; 5 patients had significant increases in blood pressure; 5 had no response. Maximal response in BP occurred by 15 min, and lasted 45-165 min. Responders could not be separated by nonresponders by analysis of baseline, hemodynamics, or prior steroid therapy; nonresponders were hemodynamically compromised greater than 24 h; responders less than or equal to 8. Two patients in each group were chronically on high-dose steroids and responded to a 2nd smaller dose of naloxone when effects of initial bolus had ended. Naloxone, 0.3 mg/kg, can reverse endorphin-mediated hypotension in acute septic shock in patients who have received chronic steroid therapy.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6307587     DOI: 10.1097/00003246-198308000-00013

Source DB:  PubMed          Journal:  Crit Care Med        ISSN: 0090-3493            Impact factor:   7.598


  9 in total

Review 1.  Naloxone dosage for opioid reversal: current evidence and clinical implications.

Authors:  Rachael Rzasa Lynn; J L Galinkin
Journal:  Ther Adv Drug Saf       Date:  2017-12-13

Review 2.  Corticosteroids, nonsteroidal anti-inflammatory drugs, and naloxone in the sepsis syndrome.

Authors:  W M Long; C L Sprung
Journal:  World J Surg       Date:  1987-04       Impact factor: 3.352

3.  Naloxone in circulatory shock.

Authors:  C Putterman; P Halpern
Journal:  Klin Wochenschr       Date:  1987-10-01

4.  Naloxone in treatment of circulatory shock resistant to conventional therapy.

Authors:  B Allolio; H Fischer; D Kaulen; U Deuss; W Winkelmann
Journal:  Klin Wochenschr       Date:  1987-03-02

Review 5.  Management of opioid analgesic overdose.

Authors:  Edward W Boyer
Journal:  N Engl J Med       Date:  2012-07-12       Impact factor: 91.245

6.  Hemodynamic response to naloxone during live Escherichia coli sepsis in splenectomized dogs.

Authors:  M Rees; J C Bowen
Journal:  Ann Surg       Date:  1984-11       Impact factor: 12.969

7.  Use of naloxone in septic shock.

Authors:  J Canady; W Williams; I Thompson; G S Vincent; E Hoover
Journal:  J Natl Med Assoc       Date:  1989-06       Impact factor: 1.798

8.  Human cardiovascular reactions to simulated hypovolaemia, modified by the opiate antagonist naloxone.

Authors:  N Foldager; F Bonde-Petersen
Journal:  Eur J Appl Physiol Occup Physiol       Date:  1988

Review 9.  Naloxone for shock.

Authors:  B Boeuf; V Poirier; F Gauvin; A M Guerguerian; C Roy; C A Farrell; J Lacroix
Journal:  Cochrane Database Syst Rev       Date:  2003
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.